Name: Emactuzumab Biosimilar, Research Grade
SKU: ARP-B00168
Availability: InStock

Elgemtumab ELISA Kit

Catalog # : ARP-BS-409

Sensitivity : 33.12 ng/mL

Detection Range : 78.125 - 5,000 ng/mL

From $1,199.00

See Details

Elipovimab Biosimilar, Research Grade

Catalog # : ARP-B00504

Target : env/Envpolyprotein

From $389.00

See Details

Elotuzumab Biosimilar, Research Grade

Catalog # : ARP-B00604

Target : SLAMF7, CRACC, Protein19A, SLAMfamilymember7, CD2-likereceptor-activatingcytotoxiccells, MembraneproteinFOAP-12, CD319, NovelLy9, CD2subset1, CS1

Reactivity : Human

From $349.00

See Details

Elotuzumab ELISA Kit

Catalog # : ARP-BS-372

Sensitivity : 21.12 ng/mL

Detection Range : 31.25 - 2,000 ng/mL

From $1,199.00

See Details

Elranatamab Biosimilar, Research Grade

Catalog # : ARP-B00740

Target : Tumornecrosisfactorreceptorsuperfamilymember17, TNFRSF17, CD269, B-cellmaturationprotein, BCMA, BCM, T3E, T-cellsurfaceantigenT3/Leu-4epsilonchain, CD3e, CD3E, T-cellsurfaceglycoproteinCD3epsilonchain

Reactivity : Human

From $499.00

See Details

Elritercept Biosimilar, Research Grade

Catalog # : ARP-B02139

Target : ACVR2, ACTRIIA, ACTR-IIA, ActivinreceptortypeIIA, ACVR2A, Activinreceptortype-2A

Reactivity : Human

From $479.00

See Details

Elsilimomab Biosimilar, Research Grade

Catalog # : ARP-B00009

Target : Hybridomagrowthfactor, BSF-2, IFN-beta-2, CDF, IL6, Interleukin-6, IL-6, B-cellstimulatoryfactor2, Interferonbeta-2, IFNB2, CTLdifferentiationfactor

Reactivity : Human

From $349.00

See Details

Eltrekibart Biosimilar, Research Grade

Catalog # : ARP-B02229

Target : CXCL1, GROA, GRO1, Neutrophil-activatingprotein3, GRO, C-X-Cmotifchemokine1, NAP-3, Growth-regulatedalphaprotein, MGSA, SCYB1, Melanomagrowthstimulatoryactivity, GRO-alpha(1-73), GROB, CXCL2, Growth-regulatedproteinbeta, Macrophageinflammatoryprotein2-alpha, SCYB2, HSF, Gro-beta, Hematopoieticsynergisticfactor, MIP2-alpha, C-X-Cmotifchemokine2, MIP2A, GRO2, SB-251353, GRO-beta-T, GRO3, CXCL3, GRO-gamma, Macrophageinflammatoryprotein2-beta, GRO-gamma(1-73), C-X-Cmotifchemokine3, GROG, Growth-regulatedproteingamma, MIP2-beta, SCYB3, C-X-Cmotifchemokine5, ENA-78(1-78), Neutrophil-activatingpeptideENA-78, ENA78, SCYB5, Small-induciblecytokineB5, CXCL5, Epithelial-derivedneutrophil-activatingprotein78, C-X-Cmotifchemokine6, SCYB6, Small-induciblecytokineB6, CXCL6, CKA-3, Chemokinealpha3, Granulocytechemotacticprotein2, GCP2, GCP-2, NAP-2, NAP-2(1-63), NAP-2(73), PPBP, CXCL7, PBP, Small-induciblecytokineB7, Macrophage-derivedgrowthfactor, LA-PF4, Leukocyte-derivedgrowthfactor, CTAP-III, CTAP-III(1-81), Low-affinityplateletfactorIV, TGB1, Beta-TG, C-X-Cmotifchemokine7, MDGF, Plateletbasicprotein, LDGF, NAP-2(74), THBGB1, NAP-2(1-66), CTAP3, SCYB7, GCP/IL-8proteinII, MDNCF, IL8/NAP1formIII, IL-8(1-77), Neutrophil-activatingfactor, GCP/IL-8proteinI, GCP/IL-8proteinVI, Interleukin-8, Chemokine(C-X-Cmotif)ligand8, Neutrophil-activatingprotein1, Monocyte-derivedneutrophilchemotacticfactor, (Ser-IL-8)72, MDNCF-b, LYNAP, GCP/IL-8proteinV, IL8/NAP1formIV, MONAP, IL8/NAP1formV, IL8/NAP1formVI, NAP-1, Granulocytechemotacticprotein1, GCP/IL-8proteinIII, IL8/NAP1formII, IL8, IL-8, CXCL8, IL8/NAP1formI, (Ala-IL-8)77, Protein3-10C, GCP/IL-8proteinIV, Emoctakin, GCP-1, C-X-Cmotifchemokine8, NAF, T-cellchemotacticfactor, MDNCF-c, Monocyte-derivedneutrophil-activatingpeptide, Lymphocyte-derivedneutrophil-activatingfactor

Reactivity : Human

From $389.00

See Details

Eluvixtamab Biosimilar, Research Grade

Catalog # : ARP-B00704

Target : MyeloidcellsurfaceantigenCD33, Sialicacid-bindingIg-likelectin3, Siglec-3, CD33, gp67, SIGLEC3, T3E, T-cellsurfaceantigenT3/Leu-4epsilonchain, CD3e, CD3E, T-cellsurfaceglycoproteinCD3epsilonchain

Reactivity : Human

From $499.00

See Details

Emactuzumab Biosimilar, Research Grade

Catalog # : ARP-B00168

Target : CD115, CSF-1receptor, CSF1R, M-CSF-R, CSF-1-R, Proto-oncogenec-Fms, Macrophagecolony-stimulatingfactor1receptor, CSF-1R, FMS

Reactivity : Human

From $349.00

See Details

Biopharmaceutical Development

Information

Customer Service

Our Partners

Biopharmaceutical Development

Categories